EA201591954A1 - Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций - Google Patents
Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекцийInfo
- Publication number
- EA201591954A1 EA201591954A1 EA201591954A EA201591954A EA201591954A1 EA 201591954 A1 EA201591954 A1 EA 201591954A1 EA 201591954 A EA201591954 A EA 201591954A EA 201591954 A EA201591954 A EA 201591954A EA 201591954 A1 EA201591954 A1 EA 201591954A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- compositions
- methods
- present
- microbial infections
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 14
- 238000000034 method Methods 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 230000003377 anti-microbal effect Effects 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- 239000004599 antimicrobial Substances 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002114 nanocomposite Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к композициям, включающим противомикробное средство и вспомогательное вещество, где композиция не содержит жирных кислот, имеющих более чем 10 атомов углерода, или их эфиров. Настоящее изобретение также относится к композициям, включающим противомикробное средство и вспомогательное вещество, где композиция имеет по меньшей мере одну жирную кислоту/один сложный эфир с углеродной цепью менее чем C11 и где композиция не содержит жирных кислот или их эфиров, имеющих более чем 10 атомов углерода. В одном воплощении настоящего изобретения композиции представляют собой нанокомпозит, в котором размер частиц по меньшей мере одного компонента находится в нанодиапазоне. Кроме того, настоящее изобретение также относится к разработке указанных композиций способом, в котором размер частиц или размер глобул состава находится в нанодиапазоне. Настоящее изобретение также обеспечивает способ получения указанных композиций или составов наряду со способами лечения микробных инфекций путем применения композиций или составов по настоящему изобретению.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1103DE2013 | 2013-04-12 | ||
PCT/IB2014/060675 WO2014167554A2 (en) | 2013-04-12 | 2014-04-12 | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201591954A1 true EA201591954A1 (ru) | 2016-04-29 |
Family
ID=50685993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591954A EA201591954A1 (ru) | 2013-04-12 | 2014-04-12 | Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций |
Country Status (9)
Country | Link |
---|---|
US (1) | US20160058775A1 (ru) |
EP (1) | EP2983714A2 (ru) |
JP (2) | JP6589086B2 (ru) |
KR (1) | KR101862448B1 (ru) |
CN (1) | CN105263525A (ru) |
AU (1) | AU2014252157B2 (ru) |
EA (1) | EA201591954A1 (ru) |
HK (1) | HK1220624A1 (ru) |
WO (1) | WO2014167554A2 (ru) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102009698B1 (ko) * | 2011-12-20 | 2019-08-13 | 바이옴 테라퓨틱스 리미티드 | 진균 감염의 치료를 위한 국소 오일 조성물 |
MY188541A (en) * | 2014-01-29 | 2021-12-21 | Vyome Therapeutics Ltd | Besifloxacin for the treatment of resistant acne |
US10772343B2 (en) | 2014-11-19 | 2020-09-15 | Kansas State University Research Foundation | Chemical mitigants in animal feed and feed ingredients |
AU2016209327A1 (en) | 2015-01-20 | 2017-08-10 | Plurogen Therapeutics, Llc | Compositions and methods of treating microbes |
US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11690815B2 (en) | 2015-08-05 | 2023-07-04 | Cmpd Licensing Llc | Hyperkeratotic skin condition treatments and compositions |
US10898455B2 (en) | 2016-01-07 | 2021-01-26 | Cmpd Licensing, Llc | Urea cream formulations |
US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US20170173063A1 (en) * | 2015-12-18 | 2017-06-22 | Cmpd Licensing, Llc | Compositions and Methods for Treating an Infection |
CN106377757B (zh) * | 2016-03-04 | 2020-05-19 | 广州英赛特生物技术有限公司 | 含氧碳氢衍生物作为多粘菌素的协同增效剂的应用 |
JP6085706B1 (ja) * | 2016-03-31 | 2017-02-22 | 株式会社ポーラファルマ | 抗トリトリコモナス剤 |
WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
JP2019521993A (ja) * | 2016-06-13 | 2019-08-08 | ビオーム セラピューティクス リミテッド | 相乗的な抗真菌組成物及びその方法 |
GB201611365D0 (en) * | 2016-06-30 | 2016-08-17 | Devenish Nutrition Ltd | A composition for use in treating rotavirus infection |
CN106178024A (zh) * | 2016-07-06 | 2016-12-07 | 安徽智博新材料科技有限公司 | 一种医用器具的长效消毒方法 |
WO2018134776A1 (en) * | 2017-01-19 | 2018-07-26 | Dr. Reddy’S Laboratories Limited | Preservative free shampoo compositions |
CA3069345A1 (en) * | 2017-07-12 | 2019-01-17 | Unilever Plc | Skin composition booster oil |
TR201714882A2 (tr) * | 2017-10-03 | 2019-04-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari |
WO2019155442A1 (en) * | 2018-02-12 | 2019-08-15 | Vyome Therapeutics Limited | Treatment of gram-negative folliculitis or an inflammation thereof with besifloxacin |
KR101961366B1 (ko) * | 2018-06-25 | 2019-03-25 | (주) 아이나노 | 금 나노 입자가 분산 함유되어 있는 항균제 혹은 소취제 조성물, 및 이를 함유한 금나노 함유 제품 |
TWI764022B (zh) * | 2018-07-30 | 2022-05-11 | 中央研究院 | 凝聚複合物的治療性奈米粒子及其治療細菌的用途 |
WO2020206459A1 (en) * | 2019-04-05 | 2020-10-08 | Northeastern University | Biosynthesis of selenium nanoparticles having antimicrobial activity |
CN114072125B (zh) * | 2019-07-09 | 2024-03-26 | 联合利华知识产权控股有限公司 | 包含抗头皮屑剂的毛发护理组合物 |
KR102241761B1 (ko) * | 2019-08-07 | 2021-04-16 | 고려대학교 산학협력단 | 상온에서 속효성 살균 효과를 갖는 조성물 |
AU2020361511A1 (en) | 2019-10-11 | 2022-04-14 | Dechra Veterinary Products, Llc | Otic formulations, methods and devices |
CN111000744B (zh) * | 2020-01-07 | 2021-10-15 | 拉芳家化股份有限公司 | 一种含协同增效去屑组合的洗发香波 |
CN111286274A (zh) * | 2020-03-06 | 2020-06-16 | 南雄市双溪丽盈化工涂料有限公司 | 高闪高透超丰满哑光清面漆 |
JP2023522982A (ja) * | 2020-04-23 | 2023-06-01 | アーチ・ユーケイ・バイオサイズ・リミテッド | アルキレングリコールエステルを含有する相乗的保存剤/パーソナルケア組成物 |
KR102197910B1 (ko) * | 2020-08-06 | 2021-01-05 | 주식회사 씨엘바이오 | 피톤치드 함유 살균 및 살바이러스 조성물 |
CN112205431A (zh) * | 2020-09-14 | 2021-01-12 | 株洲千金药业股份有限公司 | 一种抑菌组合物和抑菌型婴幼儿衣物洗液及其制备方法 |
CN112089684A (zh) * | 2020-10-30 | 2020-12-18 | 华东医药(西安)博华制药有限公司 | 左奥硝唑/奥硝唑水包油乳温敏凝胶栓剂及其制备方法 |
CN112263499B (zh) * | 2020-11-27 | 2023-05-23 | 佛山市南海东方澳龙制药有限公司 | 一种具有抗菌功能的动物香波及制备方法 |
FR3124077A1 (fr) * | 2021-06-22 | 2022-12-23 | Nanyang Technological University | Utilisation d ’ un acide gras à cha î ne courte comme agent antipelliculaire |
WO2022197625A1 (en) * | 2021-03-15 | 2022-09-22 | Drugarray, Inc. | Combination therapy for treating covid-19 |
WO2022197626A1 (en) * | 2021-03-15 | 2022-09-22 | Drugarray, Inc. | Combination therapy for treating covid-19 |
WO2022197627A1 (en) * | 2021-03-15 | 2022-09-22 | Drugarray, Inc. | Combination therapy for treating covid-19 |
WO2022258404A1 (en) | 2021-06-09 | 2022-12-15 | Unilever Ip Holdings B.V. | Topical composition for restoring microbial diversity of scalp |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4406884A (en) * | 1981-06-23 | 1983-09-27 | The Procter & Gamble Company | Topical antimicrobial composition |
EP0116439A3 (en) | 1983-02-02 | 1986-01-29 | Suntory Limited | Fatty acid containing hair tonic composition |
DE3339236A1 (de) * | 1983-10-28 | 1985-05-09 | Bayer Ag | Arzneimittelzubereitung |
US5198209A (en) * | 1992-02-11 | 1993-03-30 | Amway Corporation | Conditioning shampoo |
ES2068762B1 (es) * | 1993-07-21 | 1995-12-01 | Lipotec Sa | Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion. |
SE9303744D0 (sv) * | 1993-11-12 | 1993-11-12 | Astra Ab | Pharmaceutical emulsion |
ES2094688B1 (es) * | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
US5624666A (en) | 1995-01-20 | 1997-04-29 | The Procter & Gamble Company | Anti-dandruff shampoos with particulate active agent and cationic polymer |
WO1999033467A1 (en) * | 1997-12-31 | 1999-07-08 | Choongwae Pharma Corporation | Method and composition of an oral preparation of itraconazole |
FR2774900B1 (fr) * | 1998-02-13 | 2000-03-31 | Ceca Sa | Shampoings antipelliculaires transparents |
FR2780889B1 (fr) * | 1998-07-10 | 2001-08-31 | Concept | Utilisation d'un inhibiteur du cytochrome p450 eventuellement en association avec un antifongique pour le traitement des mycoses |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6623765B1 (en) * | 2000-08-01 | 2003-09-23 | University Of Florida, Research Foundation, Incorporated | Microemulsion and micelle systems for solubilizing drugs |
US6500861B1 (en) * | 2000-08-23 | 2002-12-31 | Michael D. Wider | Antimicrobial composition and methods of use in the treatment of disease |
US6673373B2 (en) * | 2001-02-01 | 2004-01-06 | Carlsbad Technology Inc. | Antifungal formulation and the methods for manufacturing and using the same |
GB0108082D0 (en) * | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
US7198794B1 (en) * | 2002-02-22 | 2007-04-03 | Lorri Riley | Topical formulation for treating fingernails and toenails |
TW200407172A (en) | 2002-10-17 | 2004-05-16 | Unilever Nv | Scalp treatment |
US20040202636A1 (en) * | 2003-04-11 | 2004-10-14 | Kaczvinsky Joseph Robert | Personal care composition containing an antidandruff component and a nonionic surfactant |
CN101115475A (zh) * | 2004-12-10 | 2008-01-30 | 塔利马治疗公司 | 用于治疗指甲单位病症的组合物和方法 |
JP2008532971A (ja) * | 2005-03-08 | 2008-08-21 | チバ ホールディング インコーポレーテッド | 特定のホスホネートにより被覆された金属酸化物ナノ粒子 |
ATE498428T1 (de) | 2006-07-07 | 2011-03-15 | Unilever Nv | Haarkonditionierungszusammensetzungen gegen schuppen |
EP1923043A1 (en) | 2006-11-16 | 2008-05-21 | KPSS-Kao Professional Salon Services GmbH | Anti-dandruff conditioner composition |
US8226965B2 (en) * | 2008-04-25 | 2012-07-24 | Nanobio Corporation | Methods of treating fungal, yeast and mold infections |
EP2174650A1 (en) * | 2008-10-08 | 2010-04-14 | Polichem SA | Modified release emulsions for application to skin or vaginal mucosa |
PT2400951T (pt) * | 2009-02-25 | 2018-11-26 | Mayne Pharma Llc | Composições de espuma tópica |
KR20120050414A (ko) * | 2009-06-19 | 2012-05-18 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 약물의 나노분산액 및 그의 제조 방법 |
WO2012017349A2 (en) * | 2010-08-02 | 2012-02-09 | Ranbaxy Laboratories Limited | An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine |
CN103108605B (zh) * | 2010-09-15 | 2015-12-09 | 西尔欧集团 | 长期抑菌化合物及其在牙科修复材料中的应用 |
US9907812B2 (en) * | 2011-06-22 | 2018-03-06 | Vyome Biosciences Pvt. Ltd. | Conjugate-based antifungal and antibacterial prodrugs |
-
2014
- 2014-04-12 EA EA201591954A patent/EA201591954A1/ru unknown
- 2014-04-12 AU AU2014252157A patent/AU2014252157B2/en not_active Ceased
- 2014-04-12 JP JP2016507106A patent/JP6589086B2/ja not_active Expired - Fee Related
- 2014-04-12 US US14/783,658 patent/US20160058775A1/en not_active Abandoned
- 2014-04-12 EP EP14722767.2A patent/EP2983714A2/en not_active Withdrawn
- 2014-04-12 KR KR1020157031844A patent/KR101862448B1/ko active IP Right Grant
- 2014-04-12 CN CN201480030144.XA patent/CN105263525A/zh active Pending
- 2014-04-12 WO PCT/IB2014/060675 patent/WO2014167554A2/en active Application Filing
-
2016
- 2016-07-20 HK HK16108710.4A patent/HK1220624A1/zh unknown
-
2018
- 2018-11-01 JP JP2018206681A patent/JP2019031561A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20150138392A (ko) | 2015-12-09 |
JP2016516765A (ja) | 2016-06-09 |
AU2014252157B2 (en) | 2017-05-11 |
KR101862448B1 (ko) | 2018-05-29 |
EP2983714A2 (en) | 2016-02-17 |
HK1220624A1 (zh) | 2017-05-12 |
WO2014167554A2 (en) | 2014-10-16 |
WO2014167554A3 (en) | 2014-12-24 |
US20160058775A1 (en) | 2016-03-03 |
AU2014252157A1 (en) | 2015-11-05 |
CN105263525A (zh) | 2016-01-20 |
JP6589086B2 (ja) | 2019-10-16 |
JP2019031561A (ja) | 2019-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591954A1 (ru) | Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций | |
PH12019501393A1 (en) | Afucosylated anti-fgfr2iiib antibodies | |
IN2014CN02890A (ru) | ||
MX2014010048A (es) | Composiciones alimenticias para animales y metodos de uso de las mismas. | |
BR112016009643A2 (pt) | composição nanoparticulada, célula dendrítica artificial, método para estimular ou intensificar uma resposta imune e método para tratar câncer | |
WO2014205451A3 (en) | Compositions and methods for modulation of target nucleic acids | |
MX2015012562A (es) | Purificacion de conjugados anticuerpo-farmaco (cafs). | |
WO2014113429A3 (en) | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | |
WO2015023976A3 (en) | Selective grp94 inhibitors and uses thereof | |
BR112017006653A2 (pt) | método para tratamento de um substrato animal | |
BR112014017716A8 (pt) | composições de ésteres de forbol, métodos para prevenir ou tratar acidente vascular cerebral e uso de ésteres de forbol | |
MY160520A (en) | Bloom Retarding Fat | |
WO2014117014A3 (en) | Refrigerant additives and compositions | |
RS54584B1 (en) | 15-HEPE PREPARATIONS AND PROCEDURES FOR THEIR USE | |
SG10201803827UA (en) | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil | |
NZ716341A (en) | Glyceride composition | |
NZ710602A (en) | Methods for reducing pyrogenicity in a seaweed extract | |
BR112019005852A2 (pt) | métodos, composições e usos relacionados aos mesmos | |
BR112015001728B8 (pt) | composições de condicionador | |
MX2018002514A (es) | Citotoxinas modificadas y su uso terapeutico. | |
AR097143A1 (es) | Composición alimenticia mineral para lamer para rumiantes y método para prepararla | |
MX2021001790A (es) | Composiciones solidas de trigliceridos y usos de estas. | |
AR095971A1 (es) | Un método de curtido respetuoso del medio ambiente | |
MY192365A (en) | Method for producing complex compositions of mixed diesters of 1,4:3,6-dianhydrohexitol | |
BR112013032567A2 (pt) | composição antiparasitária que compreende uma lactona macrocíclica e levamisol e método de tratamento de infestação parasitária |